You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 26 No. 1, January 1972 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Uptake and Binding of Catecholamines

Effect of Diphenylhydantoin and a New Mechanism of Action

M. Gary Hadfield, MD

Arch Neurol. 1972;26(1):78-84.


Abstract

Diphenylhydantoin altered the uptake and binding of catecholamines in rat brain. This effect has not been reported previously. In synaptosomes, uptake of radioactively labeled norepinephrine was stimulated under anoxic conditions while uptake was inhibited under more physiologic conditions. In intact brain slices uptake of dopamine labeled with tritiated water was inhibited in caudate-putamen and stimulated in hypothalamus. Subcellular distribution studies of diphenylhydantoin labeled with carbon 14 showed differential binding of the drug to several subcellular fractions. The binding of diphenylhydantoin sodium to microsomes and synaptosomes may alter the synthesis or activity of ATPase, an enzyme controlling neurotransmitter uptake and binding. The effect of diphenylhydantoin on neurotransmitters appears to warrant additional investigation as a possible mechanism for the control of seizures by that drug.



Author Affiliations

New York and Richmond, Va

From the departments of pathology and psychiatry, New York University School of Medicine, New York, and the Department of Pathology, Division of Neuropathology, Medical College of Virginia, Virginia Commonwealth University, Richmond, Va.


Footnotes

Accepted for publication June 18, 1971.

Reprint requests to Division of Neuropathology, Medical College of Virginia, Box 17, Health Sciences Center, Richmond, Va 23219 (Dr. Hadfield).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Telemetered EEG-EOG During Psychotic Behaviors of Schizophrenia
Stevens et al.
Arch Gen Psychiatry 1979;36:251-262.
ABSTRACT  

Phenytoin and Cerebellar Lesions: Similar Effects on Cerebral Catecholamine Metabolism
Snider and Snider
Arch Neurol 1977;34:162-167.
ABSTRACT  

Diphenylhydantoin: Blocking of Levodopa Effects
Mendez et al.
Arch Neurol 1975;32:44-46.
ABSTRACT  

Zinc, Taurine, and Epilepsy
Barbeau and Donaldson
Arch Neurol 1974;30:52-58.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1972 American Medical Association. All Rights Reserved.